Browse CATs

Browse CATs  internal medicine  pulmonary medicine  pulmonary embolism

Diagnosis Economics Harm/ aetiology Prognosis Therapy

Deep vein thrombosis vena caval filters were not helpful in combination with anticoagulation. Level of evidence 1b Expiry Date May 2003 Pleuritic pain reduced by indomethacin. Level of evidence 1b Expiry Date September 2003 Pulmonary embolism LMWH was probably as good as heparin. Level of evidence 1b- Expiry Date September 2003 Pulmonary embolism no clear role for thrombolysis with tPA. Level of evidence 1b- Expiry Date October 2003 Pulmonary embolism vena caval filters reduced PE in trauma patients. Level of evidence 4 Expiry Date September 2003 Pulmonary embolism anticoagulation reduced mortality and recurrence. Level of evidence 1b Expiry Date October 2005 Pulmonary embolism no clear role for tPA as a bolus. Level of evidence 1b- Expiry Date October 2003 Pulmonary embolism no clear advantage between tPA and urokinase. Level of evidence 1b Expiry Date October 2003 Pulmonary embolism no clear role for thrombolysis with tPA. Level of evidence 1b- Expiry Date October 2003 Pulmonary embolism no clear benefit from streptokinase. Level of evidence 1b- Expiry Date October 2003 Pulmonary embolism urokinase increased bleeding without reducing death or recurrent PE. Level of evidence 1b Expiry Date October 2003 Venous thromboembolism LMWH was probably as good as heparin. Level of evidence 1b- Expiry Date Venous thromboembolism indefinite warfarin decreased recurrence. Level of evidence 1b Expiry Date September 2003 Venous thromboembolism idiopathic: indefinite anticoagulation reduced recurrent episodes. Level of evidence 1b Expiry Date October 2003